Difficulty: Medium
Average Score: 69%
Practice
Which of the the following is used in acromegaly & in carcinoid syndrome:
Correct answer
A
Rationale
In the context of chemotherapy drugs, the correct answer is A) Octreotide. Octreotide is a somatostatin analog that is commonly used in the treatment of acromegaly and carcinoid syndrome. In acromegaly, Octreotide helps to reduce the excessive production of growth hormone, while in carcinoid syndrome, it controls the symptoms caused by the release of serotonin and other vasoactive substances from neuroendocrine tumors.
Option B) Degarelix is a gonadotropin-releasing hormone antagonist primarily used in the treatment of advanced prostate cancer by suppressing the production of testosterone. This mechanism of action does not apply to acromegaly or carcinoid syndrome.
Option C) Nafarelin is a gonadotropin-releasing hormone agonist used in the management of conditions such as endometriosis, central precocious puberty, and infertility. It is not indicated for acromegaly or carcinoid syndrome.
Option D) Terlipressin is a synthetic analog of vasopressin primarily used in the management of hepatorenal syndrome and variceal bleeding. It does not have a direct role in the treatment of acromegaly or carcinoid syndrome.
In an educational context, understanding the specific indications of chemotherapy drugs is crucial for healthcare professionals involved in the management of cancer and endocrine disorders. Knowledge of the mechanisms of action and appropriate clinical applications of these drugs ensures safe and effective patient care. By grasping the distinctions between various drug options, healthcare providers can make informed decisions to optimize treatment outcomes for their patients.
Option B) Degarelix is a gonadotropin-releasing hormone antagonist primarily used in the treatment of advanced prostate cancer by suppressing the production of testosterone. This mechanism of action does not apply to acromegaly or carcinoid syndrome.
Option C) Nafarelin is a gonadotropin-releasing hormone agonist used in the management of conditions such as endometriosis, central precocious puberty, and infertility. It is not indicated for acromegaly or carcinoid syndrome.
Option D) Terlipressin is a synthetic analog of vasopressin primarily used in the management of hepatorenal syndrome and variceal bleeding. It does not have a direct role in the treatment of acromegaly or carcinoid syndrome.
In an educational context, understanding the specific indications of chemotherapy drugs is crucial for healthcare professionals involved in the management of cancer and endocrine disorders. Knowledge of the mechanisms of action and appropriate clinical applications of these drugs ensures safe and effective patient care. By grasping the distinctions between various drug options, healthcare providers can make informed decisions to optimize treatment outcomes for their patients.